IRIX
$1.33+0.00 (+0.00%)
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo...
Recent News
Zacks Initiates Coverage of Iridex With Neutral Recommendation
Discover why Zacks initiated coverage of IRIX with a "Neutral" rating, being the first on Wall Street to initiate coverage on the stock. Learn how global sales momentum and stronger liquidity are balanced against margin pressures and dependency on a key distributor.
IRIDEX Corp (IRIX) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic Cost Management
IRIDEX Corp (IRIX) reports its fourth consecutive quarter of revenue growth, driven by strong glaucoma product sales and strategic cost-saving measures.
Iridex: Q3 Earnings Snapshot
MOUNTAIN VIEW, Calif. AP) — Iridex Corp. IRIX) on Tuesday reported a loss of $1.6 million in its third quarter.
IRIDEX Corp (IRIX) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Cost Challenges
IRIDEX Corp (IRIX) reports a 7% year-over-year revenue increase and continues its cost reduction strategy, despite facing margin pressures and international market challenges.
Iridex: Q2 Earnings Snapshot
MOUNTAIN VIEW, Calif. AP) — Iridex Corp. IRIX) on Tuesday reported a loss of $994,000 in its second quarter.